205
15. Actor J (2014) Introductory immunology. 1st edition - basic concepts for interdisciplinary
applications. Academic. ISBN: 9780124200302
16. Abbas A, Lichtman AH, Pillai S (2014) Cellular and molecular immunology, 8th edn,
Saunders, ISBN: 9780323316149
17. Leppla SH, Robbins JB, Schneerson R et al (2002) Development of an improved vaccine for
anthrax. J Clin Invest 110:141–144
18. Metzger DW, Bakshi CS, Kirimanjeswara G (2007) Mucosal immunopathogenesis of
Francisella tularensis. Ann N Y Acad Sci 1105:266–283
19. Kappler J, Kotzin B, Herron L et al (1989) V beta-specific stimulation of human T cells by
staphylococcal toxins. Science 244:811–813
20. White J, Herman A, Pullen AM et al (1989) The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell
56:27–35
21. Murphy K (2011) Janeway’s immunobiology, 8th edition. Garland Science. ISBN-10:
0815342438
22. Abbas AK, Lichtman AH (2010) Basic immunology, 3rd edn. Saunders Kindle Edition ISBN10: 141605569X
23. Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis
47:401–409
24. Heidelberger M, Avery OT (1923) The soluble specific substance of pneumococcus. J Exp
Med 38:73–79
25. Ausubel FM (2005) Are innate immune signaling pathways in plants and animals conserved?
Nat Immunol 6:973–979
26. Rumbo M, Nempont C, Kraehenbuhl J-P, Sirard J-C (2006) Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and toll-like receptor 5. FEBS Lett
(12):2976–2984
27. Shetty N, Aarons E, Andrews J (2009) Structure and functions of microbes. In: Shetty N, Tang
JW, Andrews J (eds) Infectious disease: pathogenesis, prevention, and case studies. Wiley,
London, p 15
28. Corbett D, Hudson T, Roberts IS (2010) Bacterial polysaccharide capsules. In: Konig H (ed)
Prokaryotic cell wall compounds. Springer, Heidelberg, p 111
29. Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: the interface of the
pathogen and the host immune system. Nat Rev Microbiol 2:747–765
30. Westphal O, Liideritz O, Bister F (1952) Ueber die Extraktion von Bakterien mit Phenol/
Wasser. Z Naturforsch. 7B:148–155
31. Pupo E, Aguila A, Santana H, Núnez JF, Castellanos-Serra L, Hardy E (1999) Mice immunization with gel electrophoresis-micropurified bacterial lipopolysaccharides. Electrophoresis
20:458–461
32. Davis MR Jr, Goldberg JB (2012) Purification and visualization of lipopolysaccharide from
Gram-negative bacteria by hot aqueous-phenol extraction. J Vis Exp 28:e3916, 1–3
33. Nagy G, Pál T (2008) Lipopolysaccharide: a tool and target in enterobacterial vaccine development. Biol Chem 389:513–520
34. Reisser D, Pance A, Jeannin JF (2002) Mechanisms of the antitumoral effect of lipid
35. Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G (1995) Outer-membrane protein- and
rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis. J
Med Microbiol 43:344–347
36. Fulop M, Mastroeni P, Green M, Titball RW (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine
19:4465–4472
37. Ada G, Isaacs D (2003) Carbohydrate-protein conjugate vaccines. Clin Microbiol
Infect 9:79–85
38. Landsteiner K (1945) The specificity of serological reactions. Harvard University Press,
Cambridge
11 Defense Against Biological Terrorism: Vaccines and Their Characterizations
15. Actor J (2014) Introductory immunology. 1st edition - basic concepts for interdisciplinary
applications. Academic. ISBN: 9780124200302
16. Abbas A, Lichtman AH, Pillai S (2014) Cellular and molecular immunology, 8th edn,
Saunders, ISBN: 9780323316149
17. Leppla SH, Robbins JB, Schneerson R et al (2002) Development of an improved vaccine for
anthrax. J Clin Invest 110:141–144
18. Metzger DW, Bakshi CS, Kirimanjeswara G (2007) Mucosal immunopathogenesis of
Francisella tularensis. Ann N Y Acad Sci 1105:266–283
19. Kappler J, Kotzin B, Herron L et al (1989) V beta-specific stimulation of human T cells by
staphylococcal toxins. Science 244:811–813
20. White J, Herman A, Pullen AM et al (1989) The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell
56:27–35
21. Murphy K (2011) Janeway’s immunobiology, 8th edition. Garland Science. ISBN-10:
0815342438
22. Abbas AK, Lichtman AH (2010) Basic immunology, 3rd edn. Saunders Kindle Edition ISBN10: 141605569X
23. Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis
47:401–409
24. Heidelberger M, Avery OT (1923) The soluble specific substance of pneumococcus. J Exp
Med 38:73–79
25. Ausubel FM (2005) Are innate immune signaling pathways in plants and animals conserved?
Nat Immunol 6:973–979
26. Rumbo M, Nempont C, Kraehenbuhl J-P, Sirard J-C (2006) Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and toll-like receptor 5. FEBS Lett
(12):2976–2984
27. Shetty N, Aarons E, Andrews J (2009) Structure and functions of microbes. In: Shetty N, Tang
JW, Andrews J (eds) Infectious disease: pathogenesis, prevention, and case studies. Wiley,
London, p 15
28. Corbett D, Hudson T, Roberts IS (2010) Bacterial polysaccharide capsules. In: Konig H (ed)
Prokaryotic cell wall compounds. Springer, Heidelberg, p 111
29. Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: the interface of the
pathogen and the host immune system. Nat Rev Microbiol 2:747–765
30. Westphal O, Liideritz O, Bister F (1952) Ueber die Extraktion von Bakterien mit Phenol/
Wasser. Z Naturforsch. 7B:148–155
31. Pupo E, Aguila A, Santana H, Núnez JF, Castellanos-Serra L, Hardy E (1999) Mice immunization with gel electrophoresis-micropurified bacterial lipopolysaccharides. Electrophoresis
20:458–461
32. Davis MR Jr, Goldberg JB (2012) Purification and visualization of lipopolysaccharide from
Gram-negative bacteria by hot aqueous-phenol extraction. J Vis Exp 28:e3916, 1–3
33. Nagy G, Pál T (2008) Lipopolysaccharide: a tool and target in enterobacterial vaccine development. Biol Chem 389:513–520
34. Reisser D, Pance A, Jeannin JF (2002) Mechanisms of the antitumoral effect of lipid
35. Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G (1995) Outer-membrane protein- and
rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis. J
Med Microbiol 43:344–347
36. Fulop M, Mastroeni P, Green M, Titball RW (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine
19:4465–4472
37. Ada G, Isaacs D (2003) Carbohydrate-protein conjugate vaccines. Clin Microbiol
Infect 9:79–85
38. Landsteiner K (1945) The specificity of serological reactions. Harvard University Press,
Cambridge
11 Defense Against Biological Terrorism: Vaccines and Their Characterizations